A comparison of group sequential and fixed sample size designs for bioequivalence trials with highly variable drugs.
Sophie I E KnahlBenjamin LangFrank FleischerMeinhard KieserPublished in: European journal of clinical pharmacology (2018)
Due to their favorable performance characteristics, two-stage GSDs are an appealing alternative to fixed sample designs when assessing bioequivalence in highly variable drugs.
Keyphrases